Medx Health Corp
OTC:MDXHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (34.6), the stock would be worth $0.05 (9% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 31.7 | $0.04 |
0%
|
| 3-Year Average | 34.6 | $0.05 |
+9%
|
| 5-Year Average | 32.4 | $0.04 |
+2%
|
| Industry Average | 1.9 | $0 |
-94%
|
| Country Average | 2.9 | $0 |
-91%
|
Forward P/S
Today’s price vs future revenue
| Today's Market Cap | Revenue | Forward P/S | ||
|---|---|---|---|---|
|
$18.1m
|
/ |
Oct 2025
CA$522.9k
|
= |
|
|
$18.1m
|
/ |
Dec 2025
CA$559.3k
|
= |
|
|
$18.1m
|
/ |
Dec 2026
CA$3.6m
|
= |
|
|
$18.1m
|
/ |
Dec 2027
CA$11.6m
|
= |
|
Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
Medx Health Corp
OTC:MDXHF
|
16.6m USD | 31.7 | -3.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 16.1 | 56.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.6B USD | 3.5 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 4.8 | 37.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 2.9 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
84.8B USD | 4.1 | 23.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 7.7 | 44 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 1.7 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.4 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
41.4B USD | 1.9 | 24.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.8 | 21 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.4 |
| Median | 2.9 |
| 70th Percentile | 4.9 |
| Max | 15 623 917.6 |
Other Multiples
Medx Health Corp
Glance View
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. Its service allows front-line healthcare providers to consult with dermatologists to offer patient care. The Company’s SIAscopy on DermSecure is a fully integrated service, which combines peer-reviewed technology with a secure, cloud-based patient management system. It’s a tool, which offers image capture technology with clinical, dermascopic and spectrophotometric views of moles and other skin conditions. The company is designed by dermatologists and physicians, its SIAscopy on DermSecure is being used in approximately 200 pharmacies in three countries with regulatory approvals in 35 countries including United States, Canada, Australia, Brazil and the European Union.
